Highlight: Molecular Medicine of Sphingolipids
The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality
Sphingolipids in viral infection
Tackling the biophysical properties of sphingolipids to decipher their biological roles
Ceramide and sphingosine in pulmonary infections
Molecular mechanisms of erythrocyte aging
Sphingolipids in liver injury, repair and regeneration
Ultrasound-stimulated microbubble enhancement of radiation response
Innate immune responses in the brain of sphingolipid lysosomal storage diseases
Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways
The role of sphingolipids in endothelial barrier function
The effect of altered sphingolipid acyl chain length on various disease models
Secretory sphingomyelinase in health and disease
Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic
Sphingomyelin breakdown in T cells: role in activation, effector functions and immunoregulation
The molecular medicine of acid ceramidase
Caenorhabditis elegans as a model to study sphingolipid signaling
S1PR4 is required for plasmacytoid dendritic cell differentiation
Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application
Downregulation of sphingosine 1-phosphate (S1P) receptor 1 by dexamethasone inhibits S1P-induced mesangial cell migration
Sphingosine kinase 2 deficiency increases proliferation and migration of renal mouse mesangial cells and fibroblasts
The life and work of Dr. Robert Bittman (1942-2014)